Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation. 2011

Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
Institute of Biochemistry and Molecular Biology, University of Bonn, Nussallee 11, 53115 Bonn, Germany.

BACKGROUND HDGF is a growth factor which is overexpressed in a wide range of tumors. Importantly, expression levels were identified as a prognostic marker in some types of cancer such as melanoma. METHODS To investigate the presumed oncogenic/transforming capacity of HDGF, we generated transgenic mice overexpressing HDGF in melanocytes. These mice were bred with mice heterozygous for a defective copy of the Ink4a tumor suppressor gene and were exposed to UV light to increase the risk for tumor development both genetically and physiochemically. Mice were analyzed by immunohistochemistry and Western blotting. Furthermore, primary melanocytes were isolated from different strains created. RESULTS Transgenic animals overexpressed HDGF in hair follicle melanocytes. Interestingly, primary melanocytes isolated from transgenic animals were not able to differentiate in vitro whereas cells isolated from wild type and HDGF-deficient animals were. Although, HDGF-/-/Ink4a+/- mice displayed an increased number of epidermoid cysts after exposure to UV light, no melanomas or premelanocytic alterations could be detected in this mouse model. CONCLUSIONS The results therefore provide no evidence that HDGF has a transforming capacity in tumor development. Our results in combination with previous findings point to a possible role in cell differentiation and suggest that HDGF promotes tumor progression after secondary upregulation and may represent another protein fitting into the concept of non-oncogene addiction of tumor tissue.

UI MeSH Term Description Entries
D008544 Melanocytes Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES. Melanocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
February 2016, Melanoma research,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
May 1996, International journal of immunopharmacology,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
June 2015, Oncotarget,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
November 2003, Journal of gastroenterology and hepatology,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
April 1999, Transfusion,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
September 2020, Life sciences,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
December 2004, Cellular and molecular life sciences : CMLS,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
November 1990, Experimental eye research,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
October 2003, Cancer,
Angela Sedlmaier, and Nicolas Wernert, and Rainer Gallitzendörfer, and Mekky M Abouzied, and Volkmar Gieselmann, and Sebastian Franken
October 1991, Cancer research,
Copied contents to your clipboard!